Results 131 to 140 of about 38,837 (270)

Understanding excessive sleep in people with psychotic disorders

British Journal of Clinical Psychology, EarlyView.
Abstract Background There has been increasing attention to sleep disturbances such as insomnia in psychosis, due to its impact on symptoms, well‐being, and recovery. However, excessive sleep and extended sleep duration are common in psychosis (partly linked to sedating antipsychotic medication) and have been relatively neglected, despite plausible ...
Kate Robbins, Joanne Hodgekins, Sarah Reeve   +2 more
wiley   +1 more source

Factors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured Adults

, 2021
Marcela Horvitz‐Lennon, Rita Volya, Simon Hollands, Katya Zelevinsky, Andrew Mulcahy, Julie M. Donohue, Sharon‐Lise T. Normand   +6 more
openalex   +2 more sources

The Recruitment and Retention of Individuals With Intellectual Disability in Randomized Controlled Trials: A Scoping Review

British Journal of Learning Disabilities, EarlyView.
ABSTRACT Background People with intellectual disabilities face significant health disparities and often encounter barriers in accessing healthcare services. Although research supports the need for reasonable adjustments to improve healthcare access for this population, implementation in acute healthcare settings remains limited.
Owen Doody, Louise Murphy, Ruth Ryan, Rosemary Lyons, Wenyi Tang, Lorna Bourke   +5 more
wiley   +1 more source

Developing a Trauma Checklist for People With a Learning Disability Accessing Community Health and Support Services

British Journal of Learning Disabilities, EarlyView.
ABSTRACT Background Research suggests people with a learning disability experience high prevalence of adverse life events which may result in trauma‐related mental health conditions. Identifying trauma‐related mental health conditions can facilitate access to support, however research suggests they may be under‐identified in this group. The aim of this
Sarah Wigham, Arman Iranpour, John L. Taylor, Claire Hills‐Wilson, Pamela Reitemeier, Katharine Petersen, Iain McKinnon, Simon S. Hackett   +7 more
wiley   +1 more source

Orthogonalization of vectors with minimal adjustment

, 2012
Two transformations are proposed that give orthogonal components with a one-to-one correspondence between the original vectors and the components.
Anaya-Izquierdo, K, Critchley, F, Garthwaite, PH, Mubwandarikwa, E   +3 more
core   +1 more source

Neuroleptic malignant syndrome associated with second-generation antipsychotics (SGA): An analysis of reported cases in eudravigilance database, 2017-2020 [PDF]

, 2021
Ana Torres, Anna Mignano, I. Viseu, Leonor Rodrigues, María Teresa Herdeiro, Luís M. Silva, Vera Afreixo   +6 more
openalex   +1 more source

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

British Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, Emma S. J. Robinson   +5 more
wiley   +1 more source

Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder

, 2011
Takaharu Azekawa, Shizuko Ohashi, Akira Itami   +2 more
openalex   +4 more sources

What is the prevalence, and what are the clinical correlates, of insulin resistance in young people presenting for mental health care? A cross-sectional study [PDF]

, 2019
Objectives: To report the distribution and predictors of insulin resistance (IR) in young people presenting to primary care-based mental health services. Design: Cross-sectional.
Carpenter, Joanne S, Cross, Shane P.M, Gehue, Jeanne, Guastella, Adam J, Hermens, Daniel F, Hickie, Ian B, Iorfino, Frank, Naismith, Sharon L, Scott, Elizabeth M, White, Django, Wilson, Chloe   +10 more
core   +1 more source

Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials

British Journal of Pharmacology, EarlyView.
Abstract Schizophrenia is regarded as a complex and heterogeneous psychiatric disorder, characterised by diverse symptoms and comorbidities, which complicate both clinical management and drug development. Current pharmacological treatment, primarily based on dopamine D2 receptor antagonism or partial agonism, which has not markedly progressed since the
Thi Viet Ha Nguyen, Declan P. McKernan, John P. Kelly   +2 more
wiley   +1 more source